Tags: Drug.

Talampanel (GYKI 537773; LY300164) is a drug which has been investigated for the treatment of epilepsy malignant gliomas and amyotrophic lateral sclerosis (ALS).As of May 2010 results from the trial for ALS have been found negative. Talampanel is not currently under development.It is a noncompetitive antagonist of the AMPA receptor a type of glutamate receptor in the central nervous system.

Talampanel_skeletal.svg
ATC prefix
none
CAS number
161832-65-1
FDA UNII code
CVS43XG1L5
IUPAC name
(8R)-7-Acetyl-5-(4-aminophenyl)-89-dihydro-8-methyl-7H-13-dioxolo[45-h] [23]benzodiazepine
PubChem
164509

Loading...

This page contains content from the copyrighted Wikipedia article "Talampanel"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.